Atlas Trials

Construction of a Recurrence Risk Prediction Model for Liver Resection Based on Drug Sensitivity of Patient-derived Hepatocellular Carcinoma Organoid

Clinical trial NCT06699524 · ACTIVE_NOT_RECRUITING

Trial details

NCT number
NCT06699524
Sponsor
Shen Feng
Status
ACTIVE_NOT_RECRUITING
Study type
OBSERVATIONAL
Hepatocellular Carcinoma
Start date
2022-09-20
Primary completion
2024-09-20
Enrollment
122

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.